Xcelience boosts solid oral dosage form capabilities

Contract research manufacturer Xcelience has expanded its solid oral dosage form capabilities by adding a Vector TFC-220 roller compactor. The new gear aids drug developers in the transition to GMP production of clinical supplies. Xcelience last March announced its alliance with three other contractors to provide a project management service that streamlines hand-offs between drugmakers and contractors throughout the various stages of drug development. Xcelience release

Suggested Articles

A few years ago, one of our Fierce editors met a Big Pharma R&D chief for the first time. “You’re the ones with the scary name,” he joked.

AstraZeneca has signed a $750 million deal to produce up to 300 million doses of Oxford University's COVID-19 vaccine by year's end.

Racing with some COVID-19 vaccine heavyweights, Novavax has brought on a partner to manufacture adjuvant for its in-development shot.